Drug-Repositioning Approaches Based on Medical and Life Science Databases

17Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

Abstract

Drug repositioning is a drug discovery strategy in which an existing drug is utilized as a therapeutic agent for a different disease. As information regarding the safety, pharmacokinetics, and formulation of existing drugs is already available, the cost and time required for drug development is reduced. Conventional drug repositioning has been dominated by a method involving the search for candidate drugs that act on the target molecules of an organism in a diseased state through basic research. However, recently, information hosted on medical information and life science databases have been used in translational research to bridge the gap between basic research in drug repositioning and clinical application. Here, we review an example of drug repositioning wherein candidate drugs were found and their mechanisms of action against a novel therapeutic target were identified via a basic research method that combines the findings retrieved from various medical and life science databases.

Cite

CITATION STYLE

APA

Zamami, Y., Hamano, H., Niimura, T., Aizawa, F., Yagi, K., Goda, M., … Ishizawa, K. (2021, November 1). Drug-Repositioning Approaches Based on Medical and Life Science Databases. Frontiers in Pharmacology. Frontiers Media S.A. https://doi.org/10.3389/fphar.2021.752174

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free